Riyadh – Mubasher: Nahdi Medical Company’s net profit decreased by 5.61% year-on-year (YoY) to SAR 480.70 million during the first half (H1) of 2024 from SAR 509.30 million.
The company’s revenue rose by 9.07% YoY to SAR 4.73 billion in H1-24 from SAR 4.33 billion in H1-23, according to interim financial results.
The earnings per share (EPS) went down to SAR 3.70 from January until the end of June from SAR 3.92 in the corresponding period a year earlier.
Quarterly Results
During the second quarter (Q2) of 2024, Nahdi Medical’s net profit edged lower by 6.52% to SAR 247.70 million from SAR 265 million.
Sales went up by 10.80% to SAR 2.47 billion in Q2-24 from SAR 2.23 billion.
Quarter-on-quarter (QoQ), the company’s net profit grew by 6.35% in Q2-24 from SAR 232.90 million in previous quarter, while sales increased by 9.53% from SAR 2.25 billion.
Cash Dividends
Nahdi Medical’s board nodded for the distribution of SAR 325 million, SAR 2.50 per share, in cash dividends for H1-24.
Dividends are set to be paid on 25 August 2024 for 130 million shares eligible until 11 August.
Nahdi Medical logged a 4.66% YoY decline in net profit to SAR 232.90 million in Q1-24 from SAR 244.30 million.
